United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

synthes for medical euipments switzerland - 1 system - device - n/a - medical devices-medical devices

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

1 system -

European Union - English - EMA (European Medicines Agency)

nordic group b.v. - methotrexate - arthritis, psoriatic, psoriasis, arthritis, juvenile rheumatoid, arthritis, rheumatoid - antineoplastic agents, - nordimet is indicated for the treatment of:active rheumatoid arthritis in adult patients,polyarthritic forms of severe, active juvenile idiopathic arthritis (jia), when the response to nonsteroidal anti-inflammatory drugs (nsaids) has been inadequate,severe recalcitrant disabling psoriasis, which is not adequately responsive to other forms of therapy such as phototherapy, psoralens and ultraviolet a (puva), and retinoids, and severe psoriatic arthritis in adult patients.

Australia - English - Department of Health (Therapeutic Goods Administration)

corin australia pty ltd - 46585 - prosthesis, knee, internal, insert component - the apex knee system ps-c tibial insert component is designed to replace the tibial articular surfaces of patients who need additional varus/valgus support. the device is made from uhmwpe and each size is available in various thicknesses to aid in obtaining appropriate soft tissue balance and joint line height. it attaches to the tibial baseplate and is intended to be used with the apex ps femur of the same size. the apex knee system ps-c tibial insert is a component of the apex primary knee system intended to replace the tibial articular surfaces of the knee joint in a primary or revision total knee replacement. the indications for use include the following: o non-inflammatory degenerative joint disease, including osteoarthritis and avascular necrosis; o rheumatoid arthritis; o correction of functional deformity; o revision procedures where other treatments or devices have failed; o cases that need additional varus/valgus support, limiting varus/valgus liftoff

Australia - English - Department of Health (Therapeutic Goods Administration)

motion is life pty ltd - 36206 - orthosis, leg, ankle/foot, unit - the valguloc is an ergonomically preformed orthosis1 for treating deformities of the big toe (hallux valgus). it is worn without shoes, usually at night when the foot is not under strain. the valguloc helps correct big toe misalignments. long-term use stretches the soft tissue and joint capsule and the toe is straightened up by applying small degrees of force. the valguloc must be individually adapted for the patient by a trained orthotist. this is the only way to guarantee its full effect and optimal wearing comfort.

Australia - English - Department of Health (Therapeutic Goods Administration)

motion is life pty ltd - 41070 - orthosis, leg, knee/ankle/foot, unit - a crooked big toe, medically known as hallux valgus, is a condition that commonly accompanies splayfoot. the condition can be exacerbated for example by high heels or too tight-fitting shoes and can result in painful inflammation of the bursa on the ball of the foot. valguloc ii is designed to bring the big toe into a therapeutically favorable position. to this end, valguloc ii can be adjusted to a variable correction angle. valguloc ii also incorporates a joint that permits physiological movement of the metatarsophalangeal joint and thus allows the wearer to walk normally in comfortable, wide-fitting shoes. when used immediately after a hallux valgus operation, your doctor can lock the movable joint in order to immobilize the toe for a short period. in this case the patient may only walk in special footware (e. g. orthopaedic shoe with a stiffened sole).

European Union - English - EMA (European Medicines Agency)

intervet international b.v. - inactivated leptospira strains: l. interrogans serogroup canicola serovar portland-vere (strain ca-12-000); l. interrogans serogroup icterohaemorrhagiae serovar copenhageni (strain ic-02-001); l. interrogans serogroup australis serovar bratislava (strain as-05-073); l. kirschneri serogroup grippotyphosa serovar dadas (strain gr-01-005) - immunologicals for canidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - dogs - for active immunisation of dogs against:l. interrogans serogroup canicola serovar canicola to reduce infection and urinary excretion;l. interrogans serogroup icterohaemorrhagiae serovar copenhageni to reduce infection and urinary excretion;l. interrogans serogroup australis serovar bratislava to reduce infection;l. kirschneri serogroup grippotyphosa serovar bananal/lianguang to reduce infection and urinary excretion.

Australia - English - Department of Health (Therapeutic Goods Administration)

corin australia pty ltd - 46585 - prosthesis, knee, internal, insert component - the apex knee system ecima ps-c tibial insert component is designed to replace the tibial articular surfaces of patients who need additional varus/valgus support. the device is made from ecima polyethylene and each size is available in various thicknesses to aid in obtaining appropriate soft tissue balance and joint line height. it attaches to the tibial baseplate and is intended to be used with the apex ps femur of the same size. the apex knee system ecima ps-c tibial insert is a component of the apex primary knee system intended to replace the tibial articular surfaces of the knee joint in a primary or revision total knee replacement. the indications for use include the following: o non-inflammatory degenerative joint disease, including osteoarthritis and avascular necrosis; o rheumatoid arthritis; o correction of functional deformity; o revision procedures where other treatments or devices have failed; o cases that need additional varus/valgus support, limiting varus/valgus liftoff

Australia - English - Department of Health (Therapeutic Goods Administration)

zimmer biomet pty ltd - 46585 - prosthesis, knee, internal, insert component - articular surface component of of the nexgen semiconstrained, nonlinked condylar knee system for use when both cruciate ligaments are excised and when greater varus/valgus constraint is required. available in multiple thicknesses to facilitate soft tissue tensioning and joint line restoration. it is made from ultra-high molecular weight polyethylene and indicated for cemented use. intended for patients with severe knee pain and disability due to rheumatoid arthritis,osteoarthritis, traumatic arthritis, polyarthritis, collagen disorders, and/or avascular necrosis of the femoral condyle post-traumatic loss of joint configuration, particularly when there is patellofemoral erosion, dysfunction or prior patellectomy, moderate valgus, varus, or flexion deformities, the salvage of previously failed surgical attempts or for a knee in which satisfactory stability in flexion cannot be obtained at the time of surgery.

Australia - English - Department of Health (Therapeutic Goods Administration)

zimmer biomet pty ltd - 32831 - uncoated knee femur prosthesis - femoral component of the nexgen semiconstrained, nonlinked condylar knee system with a non-coated fixation surface. for use when both cruciate ligaments are excised and when greater varus/valgus constraint is required. it is made from zimaloy? cobalt-chromium-molybdenum alloy and indicated for cemented use. intended for patients with severe knee pain and disability due to rheumatoid arthritis, osteoarthritis, traumatic arthritis, polyarthritis, collagen disorders, and/or avascular necrosis of the femoral condyle, post-traumatic loss of joint configuration, particularly when there is patellofemoral erosion, dysfunction or prior patellectomy, moderate valgus, varus, or flexion deformities, the salvage of previously failed surgical attempts or for a knee in which satisfactory stability in flexion cannot be obtained at the time of surgery.